Abstract | OBJECTIVE: METHODS: RESULTS:
Riboflavin deficiency was frequently found among the study population (33.8%). Incidence rose toward the end of pregnancy (27.3% at 29-36 weeks' gestation compared with 53.3% at over 36 weeks). In the riboflavin-deficient group, mothers were more likely to develop preeclampsia (28.8%) than in the riboflavin-adequate group (7.8%; P <.001, odds ratio [OR] 4.7, 95% confidence interval [CI] 1.8-12.2). The calculated concentrations of intracellular free flavin adenine dinucleotide were significantly lower in patients who developed preeclampsia than in normal pregnancies (P <.05). CONCLUSION:
|
Authors | J Wacker, J Frühauf, M Schulz, F M Chiwora, J Volz, K Becker |
Journal | Obstetrics and gynecology
(Obstet Gynecol)
Vol. 96
Issue 1
Pg. 38-44
(Jul 2000)
ISSN: 0029-7844 [Print] United States |
PMID | 10862839
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adult
- Female
- Glutathione Reductase
(blood)
- Humans
- Pre-Eclampsia
(epidemiology)
- Pregnancy
- Pregnancy, High-Risk
- Prospective Studies
- Riboflavin Deficiency
(epidemiology)
- Risk Factors
- Zimbabwe
(epidemiology)
|